In this episode, Dr Elle Wadsworth talks to Dr Myfanwy Graham, a Postgraduate Scholar at Monash University funded by the Australian Government's National Health and Medical Research Council. The interview covers Myfanwy’s data insight paper examining differences in the measurement of medical cannabis use. Why definitions and contexts matter with regards to medical cannabis use [01:05]Four measures of medical cannabis use that Myfanwy explored in the study [02:05]The medical cannabis policy contexts of the US, Australia, and Canada [03:30]The importance of using standardised questions across different countries [05:18]The main findings of the data insight [05:48]Interpretations of medical cannabis use [07:49]The implications of the findings for policy and practice [08:23]Myfanwy’s preferred measure of medical cannabis use [09:30]Self perceptions of being a medical cannabis consumer [10:34]The take-home messages of the study [11:56]About Elle Wadsworth: Elle is an academic fellow with the Society for the Study of Addiction. She is based at the University of Bath with the Addiction and Mental Health Group and her research interests include drug policy, cannabis legalisation, and public health.About Myfanwy Graham: Myfanwy is a Postgraduate Scholar funded by the Australian Government's National Health and Medical Research Council and a Monash Research Excellence Scholar at the Monash Addiction Research Centre, Monash University. Her research examines the intersection between drug policy and health outcomes with psychoactive medicines (e.g. medical cannabis, psychedelics). She is also a current Fellow at the Schaeffer Center for Health Policy and Economics at the University of Southern California and is a Fulbright Scholar Alumna in public health policy. Myfanwy has completed consultancy work for the Australian Government Department of Health, Disability and Ageing, World Health Organization, the United Nations Office on Drugs and Crime and the National Academies of Sciences, Engineering, and Medicine. She is also a registered pharmacist.Authors have no conflicts of interest to declare.Original article: Understanding medical cannabis use internationally: Why definitions and context matter https://doi.org/10.1111/add.70117The opinions expressed in this podcast reflect the views of the host and interviewees and do not necessarily represent the opinions or official positions of the SSA or Addiction journal.The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information. Hosted on Acast. See acast.com/privacy for more information.
--------
13:15
--------
13:15
Health claims about US cannabis products with Tim Mackey and Doug Roehler
In this episode, Dr Elle Wadsworth talks to Dr Tim Mackey and Dr Doug Roehler. Tim is a professor in the Global Health Program at UC San Diego and the CEO and co-founder of S-3 Research, and Doug is the Cannabis Research Unit lead in the Department of Policy and Research for California’s Department of Cannabis Control. The interview covers Tim and Doug’s research article exploring the health benefit claims of cannabis products on online marketplaces in the United States. Why exploring health benefit claims on cannabis products was an important topic to investigate [01:20]What are cannabis-derived products? [03:07]What are the online marketplaces ‘Leafly’ and ‘Weedmaps’? [03:35]Examples of health benefit claims [05:00]The main findings of the study [07:33]The cannabis regulatory environment in the US [10:20]The differences in health claims between different types of cannabis products [12:20]The methodology used in the study that brought together data scientists and public health researchers [14:11]The health claims that surprised Tim and Doug [18:31]About Elle Wadsworth: Elle is an academic fellow with the Society for the Study of Addiction. She is based at the University of Bath with the Addiction and Mental Health Group and her research interests include drug policy, cannabis legalisation, and public health. She has a BSc in Chemistry, an MSc in Addiction Studies, and a PhD in Public Health. About Tim Ken Mackey: Tim is a Professor in the Global Health Program at UC San Diego and the CEO and co-founder of S-3 Research, a public health data science company originally created from a Challenge.gov award. He is also the Director of the Global Health Policy and Data Institute and the Editor-in-Chief of JMIR Infodemiology. He has co-authored over 270 manuscripts on topics including global health, technology, data science, substance use disorder, and health policy. Dr Mackey is an entrepreneur and scientist working on technology innovation to address public health challenges. About Douglas Roehler: Doug leads the Cannabis Research Unit in the Department of Policy and Research for California’s Department of Cannabis Control. Previously, he was a health scientist and epidemiologist in the Division of Overdose Prevention at the CDC, where he primarily served in the CDC’s Cannabis Strategy Unit. He has published extensively on cannabis topics in peer-reviewed journals and governmental reports, appeared on national podcasts, and represented the CDC in the national media. He has published widely on several other topics, including injury prevention, drug overdose and substance use, youth prevention, syndromic surveillance, traffic crashes, and youth violence. Declarations of Interest: Tim Mackey is the CEO and co-founder of the company S-3 Research and holds equity/ownership in the company. S-3 Research is a small business that has received funding through government contracts and grants for professional and technology services including on topics related to substance use disorder.Original article: Exploratory analysis of United States-based cannabis product health benefit claims on online marketplaces https://doi.org/10.1111/add.70177The opinions expressed in this podcast reflect the views of the host and interviewees and do not necessarily represent the opinions or official positions of the SSA or Addiction journal.The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information. Hosted on Acast. See acast.com/privacy for more information.
--------
21:58
--------
21:58
A smartphone app for reducing alcohol use with Joshua Garfield
In this episode, Dr Tsen Vei Lim speaks to Dr Joshua Garfield, a research fellow at Monash University and Turning Point, Australia. The interview covers Joshua’s research article on the efficacy of a personalised alcohol ‘approach bias modification’ smartphone app in people accessing outpatient treatment for alcohol use disorders.What is ‘approach bias modification’ [01:51]The smartphone app and how it works [04:30]The recruitment process of the randomised controlled trial [07:20]The key findings of the study [09:20]How did the participants of the study feel about using the app? [10:37]The implications of the study for practice [12:33]The next steps for this app and using the app in different populations [13:54]About Tsen Vei Lim: Tsen Vei is an academic fellow supported by the Society for the Study of Addiction, currently based at the Department of Psychiatry at the University of Cambridge. His research integrates computational modelling, experimental psychology, and neuroimaging to understand the neuropsychological basis of addictive behaviours. He holds a PhD in Psychiatry from the University of Cambridge (UK) and a BSc in Psychology from the University of Bath (UK).About Joshua Garfield: Joshua completed a Bachelor of Science with Honours in Psychology at the University of Tasmania in 2002, and then a PhD in Behavioural Neuroscience at the University of New South Wales in 2008, where he studied animal learning theory. Following a brief post-PhD role in depression research, he moved to Melbourne to work for Monash University at Turning Point, an addiction treatment, research, and workforce training institute. Since 2015, he has managed Turning Point’s cognitive bias modification research program, led by Professor Victoria Manning.Original article: Efficacy of a personalised alcohol approach bias modification smartphone app in people accessing outpatient alcohol use disorder treatment: A randomised controlled trial https://doi.org/10.1111/add.70184The opinions expressed in this podcast reflect the views of the host and interviewees and do not necessarily represent the opinions or official positions of the SSA or Addiction journal.The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information. Hosted on Acast. See acast.com/privacy for more information.
--------
15:55
--------
15:55
What wastewater reveals about drug use in Hanoi, Vietnam with Phong Thai
In this episode, Dr Elle Wadsworth talks to Dr Phong Thai, an Associate Professor at Queensland Alliance for Environmental Health Sciences, Australia. The interview covers Phong’s research article on a wastewater study measuring illegal drug use in Hanoi, Vietnam, to determine the feasibility of conducting wastewater analysis in a low-income country.Note: The acronym ‘UNODC’ used in this episode stands for the ‘United Nations Office on Drugs and Crime’. Why looking at illegal drug use in Vietnam is important [01:07]Wastewater analysis and its utility in a low-income country [02:00]The biomarkers of focus [03:55]Why the authors chose Hanoi, Vietnam, to pilot wastewater analysis in South East Asia [05:38]Vietnam’s location and relation to drug trafficking in South East Asia [07:12]The Golden Triangle [08:22]The main findings of the study [08:48]Ketamine’s rise in popularity in Vietnam [10:16]The impact of COVID-19 on the consumption of drugs in Vietnam [11:18]Why are synthetic drugs becoming more popular? [12:30]The feasibility of conducting wastewater analysis in a low-income country [13:33]The take-home messages of the study [15:34]About Elle Wadsworth: Elle is an academic fellow with the Society for the Study of Addiction. She is based at the University of Bath with the Addiction and Mental Health Group and her research interests include drug policy, cannabis legalisation, and public health.About Phong Thai: Phong is an ARC Mid-Career Industry Fellow and Associate Professor at Queensland Alliance for Environmental Health Sciences (QAEHS). His research focus involves the expansion of wastewater-based epidemiological approach to estimate community consumption and exposure to a range of legal and illegal substances (including tobacco and alcohol) and pharmaceuticals, as well as the monitoring of community infection to COVID-19 during the last pandemic. He is a member of the team who manage the National Wastewater Drug Monitoring Program in Australia and has helped pioneering wastewater drug monitoring in several countries.Original article: Significant changes in preference of illicit drug use in a population of Hanoi, Vietnam – A 6-year wastewater study (2018–2023) https://doi.org/10.1111/add.70147The opinions expressed in this podcast reflect the views of the host and interviewees and do not necessarily represent the opinions or official positions of the SSA or Addiction journal.The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information. Hosted on Acast. See acast.com/privacy for more information.
--------
17:06
--------
17:06
MDMA, anxiety, and depression with Zachary Bryant
In this episode, Dr Tsen Vei Lim talks to Zachary Bryant, a PhD candidate at the Matilda Centre for Research in Mental Health and Substance Use, University of Sydney, Australia. The interview covers Zachary’s research report on the relationship between MDMA (or ecstasy) use in youth adulthood and anxiety or depressive disorders in later adult life. The effects of MDMA [1:20]The prevalence of MDMA use and reasons why people take it [02:00]The relevance of MDMA for depression and anxiety [03:05]The use of the Victorian Adolescent Health Cohort Study to answer Zachary’s research question [04:17]The key findings of the study [06:50]Some reasons to explain the relationship found between MDMA use and anxiety but not depression [07:43]The self-medication hypothesis [10:04]The implication of the findings for clinical practice [11:02]The importance of replicating the findings in different cohorts and with more recent data [14:03] About Tsen Vei Lim: Tsen Vei is an academic fellow supported by the Society for the Study of Addiction, currently based at the Department of Psychiatry at the University of Cambridge. His research integrates computational modelling, experimental psychology, and neuroimaging to understand the neuropsychological basis of addictive behaviours. He holds a PhD in Psychiatry from the University of Cambridge (UK) and a BSc in Psychology from the University of Bath (UK). About Zachary Bryant: Zachary is a PhD candidate and research officer at the University of Sydney’s Matilda Centre for Research in Mental Health and Substance Use. His doctoral research examines the relationship between MDMA (ecstasy) use and mood, with a focus on implications for therapeutic applications. More broadly, his work explores the epidemiology of psychedelic use and applies advanced causal approaches to substance use research. He is particularly interested in emerging data collection and analysis methods, including intensive longitudinal designs such as Ecological Momentary Assessment (EMA).The authors have no conflicts of interest to disclose. Original article: The relationship between 3,4-methylenedioxymethamphetamine (MDMA) use in young adulthood and anxiety or depressive disorders in the mid-30s: Findings from the Victorian Adolescent Health Cohort Study - https://doi.org/10.1111/add.70173The opinions expressed in this podcast reflect the views of the host and interviewees and do not necessarily represent the opinions or official positions of the SSA or Addiction journal.The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information. Hosted on Acast. See acast.com/privacy for more information.
Welcome to the podcast from the journal Addiction. The podcast includes interviews with Addiction authors about their work, details about publishing in the journal, and other topics of interest to the field of addiction. This podcast is for researchers, clinicians, students, people with lived experience, and anyone with an interest in the topic. For Season 3, our interviewers are: Dr Elle Wadsworth, Dr Tsen Vei Lim, Dr Chloe Burke, and Dr Zoe Swithenbank. Hosted on Acast. See acast.com/privacy for more information.
Netherlands